WXXWY
Price
$6.90
Change
-$0.19 (-2.68%)
Updated
Jun 13 closing price
Capitalization
14.51B
72 days until earnings call
ZLAB
Price
$41.00
Change
-$2.03 (-4.72%)
Updated
Jun 13 closing price
Capitalization
4.63B
58 days until earnings call
Interact to see
Advertisement

WXXWY vs ZLAB

Header iconWXXWY vs ZLAB Comparison
Open Charts WXXWY vs ZLABBanner chart's image
Wuxi Biologics (Cayman)
Price$6.90
Change-$0.19 (-2.68%)
Volume$109.89K
Capitalization14.51B
Zai Lab
Price$41.00
Change-$2.03 (-4.72%)
Volume$1.02M
Capitalization4.63B
WXXWY vs ZLAB Comparison Chart
Loading...
WXXWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
WXXWY vs. ZLAB commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is WXXWY is a Buy and ZLAB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (WXXWY: $6.90 vs. ZLAB: $41.00)
Brand notoriety: WXXWY and ZLAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: WXXWY: 277% vs. ZLAB: 84%
Market capitalization -- WXXWY: $14.51B vs. ZLAB: $4.63B
WXXWY [@Biotechnology] is valued at $14.51B. ZLAB’s [@Biotechnology] market capitalization is $4.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

WXXWY’s FA Score shows that 1 FA rating(s) are green whileZLAB’s FA Score has 0 green FA rating(s).

  • WXXWY’s FA Score: 1 green, 4 red.
  • ZLAB’s FA Score: 0 green, 5 red.
According to our system of comparison, WXXWY is a better buy in the long-term than ZLAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

WXXWY’s TA Score shows that 6 TA indicator(s) are bullish while ZLAB’s TA Score has 6 bullish TA indicator(s).

  • WXXWY’s TA Score: 6 bullish, 4 bearish.
  • ZLAB’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both WXXWY and ZLAB are a good buy in the short-term.

Price Growth

WXXWY (@Biotechnology) experienced а +12.75% price change this week, while ZLAB (@Biotechnology) price change was +7.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

WXXWY is expected to report earnings on Aug 25, 2025.

ZLAB is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WXXWY($14.5B) has a higher market cap than ZLAB($4.63B). ZLAB (56.548) and WXXWY (55.844) have similar YTD gains .
WXXWYZLABWXXWY / ZLAB
Capitalization14.5B4.63B313%
EBITDAN/A-236.44M-
Gain YTD55.84456.54899%
P/E Ratio31.82N/A-
RevenueN/A418M-
Total CashN/A757M-
Total DebtN/A192M-
FUNDAMENTALS RATINGS
WXXWY vs ZLAB: Fundamental Ratings
WXXWY
ZLAB
OUTLOOK RATING
1..100
5817
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6093
PRICE GROWTH RATING
1..100
3736
P/E GROWTH RATING
1..100
7100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZLAB's Valuation (52) in the Biotechnology industry is in the same range as WXXWY (72) in the null industry. This means that ZLAB’s stock grew similarly to WXXWY’s over the last 12 months.

ZLAB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as WXXWY (100) in the null industry. This means that ZLAB’s stock grew similarly to WXXWY’s over the last 12 months.

WXXWY's SMR Rating (60) in the null industry is somewhat better than the same rating for ZLAB (93) in the Biotechnology industry. This means that WXXWY’s stock grew somewhat faster than ZLAB’s over the last 12 months.

ZLAB's Price Growth Rating (36) in the Biotechnology industry is in the same range as WXXWY (37) in the null industry. This means that ZLAB’s stock grew similarly to WXXWY’s over the last 12 months.

WXXWY's P/E Growth Rating (7) in the null industry is significantly better than the same rating for ZLAB (100) in the Biotechnology industry. This means that WXXWY’s stock grew significantly faster than ZLAB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
WXXWYZLAB
RSI
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
76%
Bearish Trend 18 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
WXXWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICPUX6.310.07
+1.12%
Integrity Mid-North American Resources C
GMOEX26.89N/A
N/A
GMO Emerging Markets III
EVSTX20.99N/A
N/A
Allspring Disciplined US Core C
GCLLX16.39N/A
N/A
Goldman Sachs Enhanced U.S. Equity C
TRWAX24.06N/A
N/A
Transamerica International Equity A

WXXWY and

Correlation & Price change

A.I.dvisor indicates that over the last year, WXXWY has been loosely correlated with WXIBF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if WXXWY jumps, then WXIBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXXWY
1D Price
Change %
WXXWY100%
-2.68%
WXIBF - WXXWY
46%
Loosely correlated
N/A
ONC - WXXWY
36%
Loosely correlated
-2.50%
SNBIF - WXXWY
28%
Poorly correlated
N/A
NAMS - WXXWY
23%
Poorly correlated
-3.90%
ZLAB - WXXWY
23%
Poorly correlated
-4.72%
More